Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines-Reference-Cited by-同舟云学术

Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines

Published:2015-06-03 Issue:6 Volume:10 Page:e0127467
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kanaoka Ryuhei,Kushiyama Akifumi,Seno Yasuyuki,Nakatsu Yusuke,Matsunaga Yasuka,Fukushima Toshiaki,Tsuchiya Yoshihiro,Sakoda Hideyuki,Fujishiro Midori,Yamamotoya Takeshi,Kamata Hideaki,Matsubara Akio,Asano Tomoichiro

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference59 articles.

1. Pinning down cell signaling, cancer and Alzheimer's disease;KP Lu;Trends Biochem Sci,2004

2. The peptidyl-prolyl isomerase Pin1;JD Joseph;Prog Cell Cycle Res,2003

3. Pinning down proline-directed phosphorylation signaling;KP Lu;Trends Cell Biol,2002

4. Pin1 promotes degradation of Smad proteins and their interaction with phosphorylated tau in Alzheimer's disease;U Ueberham;Neuropathol Appl Neurobiol,2014

5. Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC;A Ryo;Nat Cell Biol,2001

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the potential of Juglans regia phytoconstituents for the treatment of cervical cancer utilizing network biology and molecular docking approach;PLOS ONE;2024-04-16

2. Proline Isomerization: From the Chemistry and Biology to Therapeutic Opportunities;Biology;2023-07-14

3. The Role of Small Interfering RNAs in Hepatocellular Carcinoma;Journal of Gastrointestinal Cancer;2023-07-11

4. Exploring phytoconstituents ofJuglans regiato treat cervical cancer using integrative Bioinformatics;2023-06-15

5. Par14 interacts with the androgen receptor, augmenting both its transcriptional activity and prostate cancer proliferation;Cancer Medicine;2022-12-30